Concepedia

Publication | Open Access

Induced pluripotent stem cell–based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients

46

Citations

10

References

2019

Year

Abstract

UMIN000036295; Pre-results, JMA-IIA00419; Pre-results.

References

YearCitations

Page 1